Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

CWP232228

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Azabicyclo CompoundsOrganophosphates

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Selective Wnt/β-catenin Small-molecule Inhibitor CWP232228 Impairs Tumor Growth of Colon Cancer
Background/Aim: To explore the possibility of a selective small-molecule β-catenin inhibitor, CWP232228, as a potential… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2016
2016
CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment
Liver cancer stem cells (CSCs) are resistant to conventional chemotherapy and radiation, which may destroy tumor masses, but not… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2015
Highly Cited
2015
Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells.
Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but… Expand
2015
2015
Wnt / b-Catenin Small-Molecule Inhibitor CWP 232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells
Breast cancer stem cells (BCSC) are resistant to conventional chemotherapy and radiotherapy, which may destroy tumor masses but… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE